BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17641969)

  • 1. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
    Pontoriero G; Pozzoni P; Vecchio LD; Locatelli F
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):201-15. PubMed ID: 17641969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Study of Health Care Organization and Financing for end-stage renal disease in France.
    Durand-Zaleski I; Combe C; Lang P
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):171-83. PubMed ID: 17680359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International study of health care organization and financing: development of renal replacement therapy in Germany.
    Kleophas W; Reichel H
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):185-200. PubMed ID: 17701342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The organization and financing of end-stage renal disease treatment in Japan.
    Fukuhara S; Yamazaki C; Hayashino Y; Higashi T; Eichleay MA; Akiba T; Akizawa T; Saito A; Port FK; Kurokawa K
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):217-31. PubMed ID: 17690980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.
    Manns BJ; Mendelssohn DC; Taub KJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
    Dor A; Pauly MV; Eichleay MA; Held PJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):73-111. PubMed ID: 17653860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The organization and financing of end-stage renal disease in Spain.
    Luño J
    Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
    Wikström B; Fored M; Eichleay MA; Jacobson SH
    Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.
    Van Biesen W; Lameire N; Peeters P; Vanholder R
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):133-48. PubMed ID: 17638074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The organization and financing of dialysis and kidney transplantation services in New Zealand.
    Ashton T; Marshall MR
    Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Study of Health Care Organization and Financing of renal services in England and Wales.
    Nicholson T; Roderick P
    Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage renal disease in Indonesia: treatment development.
    Prodjosudjadi W; Suhardjono A
    Ethn Dis; 2009; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis Care and Dialysis Funding in Asia.
    Tang SCW; Yu X; Chen HC; Kashihara N; Park HC; Liew A; Goh BL; Nazareth MGC; Bunnag S; Tan J; Lun V; Lydia A; Sharma SK; Hoque E; Togtokh A; Ghnaimet M; Jha V
    Am J Kidney Dis; 2020 May; 75(5):772-781. PubMed ID: 31699518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The organization and funding of the treatment of end-stage renal disease in Australia.
    Harris A
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):113-32. PubMed ID: 17763938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Using Dialysis and Transplantation Registries for regional and small-area epidemiology].
    Vitullo F
    G Ital Nefrol; 2003; 20(2):151-9. PubMed ID: 12746800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of renal replacement therapy services in Ghana.
    Antwi S
    Blood Purif; 2015; 39(1-3):137-40. PubMed ID: 25659989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of disease - prevalence and incidence of ESRD in selected European regions and populations.
    Covic A; Schiller A
    Clin Nephrol; 2010 Nov; 74 Suppl 1():S23-7. PubMed ID: 20979959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.